View
2
Download
0
Category
Preview:
Citation preview
Grants Reporting
The following table details all grants that Cancer Australia has funded since 1 January 2009.
Agency
Program Title
Program Component
(if applicable)
Recipient
Purpose
Value
Date of Effect
Grant Term (months)
Grant Funding Location
Postcode
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Cancer Council Victoria
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A web-based intervention to reduce distress and improve quality of life among younger women with breast cancer: A RCT. App562002. CA-A0809/05
$109,937.18
15/12/2008
53
Carlton
3053
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Towards new screening tests for oesophageal adenocarcinoma Appl ID: 552449
$512,325
01/01/2009
59
Herston QLD
4006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Newcastle
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Targeting p53 isoforms, Δ40p53 and p53β, to promote chemo-sensitivity in human melanoma. App569284. CA-A0809/49
$20,625
04/01/2009
12
Callaghan
2308
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Queensland Health
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Phase II Efficacy Study of Chemo-Radiotherapy in PET Staged II-III Merkel Cell Carcinoma of the Skin. App551200. CA-A0809/06
$101,750
13/01/2009
72
Woolloongabba
4102
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Psychological morbidity, unmet needs, quality of life and patterns of care in migrant cancer patients: The first year. App571009. CA-A0809/37
$20,229.83
14/01/2009
12
Sydney
2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
The University of Wollongong
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: In vivo assessment of small molecule uPA-directed prodrugs for the treatment of malignant disease. App573432. CA-A0809/09
$20,556.25
14/01/2009
25
Wollongong
2522
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: The role of intraprostatic glucocorticoid action in prostate physiology and pathology. App571311. CA-A0809/10
$20,229.83
14/01/2009
12
Sydney
2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Identification of candidate tumour suppressor genes inactivated by promoter methylation in melanoma cell lines. App552466. CA-A0809/25
$20,556.25
20/01/2009
12
Herston
4006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Response to chemotherapy in ovarian cancer. App552481. CA-A0809/22
$625,625
20/01/2009
39
Herston
4006
Cancer Australia
Support for Cancer Clinical Trials Program and Boost Cancer Research Program
Primary Care Collaborative Clinical trials Group (PC4TG) through University of Western Australia
Support for Cancer Clinical Trials Program - CA-A0910/16
$311,230.70
27/01/2009
17
University of WA, WA
6009
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Macquarie University
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Evaluation of an online decision aid for women with breast cancer considering reconstructive surgery. App543400. CA-A0809/29
$103,803.34
30/01/2009
60
North Ryde
2109
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: The Renin Angiotensin System – a Novel Target in the Treatment of Colorectal Liver Metastases. App566536. CA-A0809/47
$20,363.20
30/01/2009
18
Parkville
3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Overcoming chemo-resistance in leukaemia: application of Vorinostat and ABT-737 to a new in vivo model of CLL. App566746. CA-A0809/46
$20,350
30/01/2009
12
Parkville
3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Characterisation of the kConFab BRCAX cohort for selected breast cancer susceptibility loci and effect on cancer risk. App566791. CA-A0809/44
$527,107.90
30/01/2009
71
Parkville
3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A randomised trial of stereotactic vs conventional radiotherapy for inoperable early stage non-small cell lung cancer. App566813. CA-A0809/45
$286,000
30/01/2009
59
Parkville
3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Methylation in ductal carcinoma in situ. App566882. CA-A0809/43
$294,398.69
30/01/2009
48
Parkville
3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Characterisation of a tumour-associated PIK3CA mutation using a novel mouse model. App566974. CA-A0809/42
$20,625
30/01/2009
12
Parkville
3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Reversing the debilitating effects of radiotherapy-induced damage in juvenile brain. App566976. CA-A0809/41
$20,625
30/01/2009
12
Parkville
3010
Cancer Australia
Support for Cancer Clinical Trials Program
Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG)
Support for Cancer Clinical Trials Program - CA-A00809/19
$770,880.00
30/01/2009
18
Parkville
3052
Cancer Australia
Support for Cancer Clinical Trials Program
Australasian Sarcoma Study Group (ASSG) through University of Melbourne
Support for Cancer Clinical Trials Program - CA-A0809/18
$760,839.20
30/01/2009
18
University of Melbourne, VIC
3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Garvan Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: DNA methylation alterations as detection markers for early ovarian cancer. App535957. CA-A0809/28
$639,375
02/02/2009
36
Darlinghurst
2010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of NSW
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Role of Heat Shock Proteins in the Stromal Reaction of Pancreatic Cancer. App568851. CA-A0809/27
$20,350
02/02/2009
12
Sydney
2052
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Melbourne Health
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Resveratrol in the chemoprevention of colorectal neoplasia. App544307. CA-A0809/39
$633,325
03/02/2009
60
Parkville
3050
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A nurse led psychosocial intervention with peer support to reduce psychosocial needs in women with gynaecological cancer. App566942. CA-A0809/40
$127,930
03/02/2009
24
Parkville
3010
Cancer Australia
Support for Cancer Clinical Trials Program
Cooperative Trials Group for Neuro-Oncology (COGNO) through University of Sydney
Support for Cancer Clinical Trials Program - CA-A0809/17
$364,455.30
03/02/2009
17
University of Sydney, NSW
2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Prince Charles Hospital
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Individualising treatment for mesothelioma. App550600. CA-A0809/48
$384,450
04/02/2009
50
Chermside
4032
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Newcastle
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Blood cancer survivors and support persons: A national survey of rural/urban unmet needs and psychological disturbance. App569290. CA-A0809/50
$285,360.90
04/02/2009
52
Callaghan
2308
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Incidence and risk factors for lymphoedema secondary to breast cancer: a prospective cohort study. App570801. CA-A0809/30
$581,916.25
04/02/2009
48
Sydney
2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Quality of life outcomes and cost effectiveness of pelvic exenteration for people with advanced rectal cancer. App570860. CA-A0809/31
$211,777.50
04/02/2009
71
Sydney
2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Phase III study in patients with Locally Advanced Pancreatic cancer: Gemcitabine +/- chemoradiotherapy & +/- erlotinib. App570948. CA-A0809/34
$284,900
04/02/2009
90
Sydney
2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Genome-wide analysis of pre-mRNA splicing regulation by RBM4. App570874. CA-A0809/32
$20,597.50
05/02/2009
12
Sydney
2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Understanding the psychosocial sequelae of surviving testicular cancer. App570961. CA-A0809/35
$104,940
05/02/2009
24
Sydney
2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Short Course Oncology Therapy - A Study of Adjuvant Chemotherapy in Colorectal Cancer by the CACTUS and OCTO Groups. App571314. CA-A0809/38
$329,752.50
05/02/2009
59
Sydney
2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: The role of melanoma stem cells in melanomagenesis. App570778. CA-A0809/21
$20,625
09/02/2009
12
Sydney
2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Southern Queensland
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A Randomized Trial of a Shorter Radiation Fractionation Schedule for the Treatment of Localized Prostate Cancer (PROFIT – Prostate Fractionated Irradiation Trial). App570403. CA-A0809/20
$487,850
12/02/2009
36
Toowoomba
4350
Cancer Australia
Support for Cancer Clinical Trials Program
Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) through University of Sydney
Support for Cancer Clinical Trials Program - CA-A0809/52
$839,905.00
18/02/2009
18
University of Sydney, NSW
2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Walter and Eliza Hall Institute
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Role of the GATA-3 transcription factor as a tumour suppressor and potential therapeutic target in breast cancer. App575572. CA-A0809/53
$326,803.95
20/02/2009
36
Parkville
3050
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Adelaide
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Faecal microflora and circulating proinflammatory cytokines: key elements to chemotherapy-induced diarrhoea. App553601. CA-A0809/54
$20,625
25/02/2009
12
Adelaide
5005
Cancer Australia
Improved Cancer Control
Improved Cancer Control
Cancer Institute NSW
The continuation of Cancer Service Networks National Demonstration Program (CanNET) in New South Wales
$932,091.60
16/03/2009
56
Alexandria, NSW
1435
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of NSW
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Development of an optimised multidisciplinary intervention for post-cancer fatigue. App568828. CA-A0809/64
$474,650
15/06/2009
61
Sydney
2052
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Adelaide
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: A combinatorial approach targeting androgen signalling for treatment of prostate cancer. App627229. CA-A0910/87
$321,028.95
01/01/2010
36
Adelaide
5005
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of South Australia
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Development of microfluidic chips to isolate and analyse peripheral blood cell populations in pancreatic cancer patients. App631921. CA-A0910/56
$24,750
06/01/2010
12
Adelaide
5001
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Ludwig Institute of Cancer Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Mechanisms of abiraterone resistance in prostate cancer. App603107. CA-A0910/57
$216,150
18/01/2010
36
Heidelberg
3084
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Garvan Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Identifying and targeting Docetaxel resistance in hormone refractory prostate cancer. App596858. CA-A0910/54
$213,950
20/01/2010
36
Darlinghurst
2010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Monash University
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: The role of the EphA3 receptor in the stromal microenvironment of tumours. App606719. CA-A0910/58
$24,750
20/01/2010
12
Clayton
3168
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Monash University
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Novel monoclonal antibodies for the diagnosis and treatment of epithelial cancers and cancer stem cells. App606552. CA-A0910/55
$94,806.80
21/01/2010
12
Clayton
3168
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Queensland
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: LACE – Laparoscopic Approach to Carcinoma of the Endometrium. An International Multicentre Randomised Phase 3 Clinical Trial. App631523. CA-A0910/46
$643,775
27/01/2010
36
Brisbane
4072
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Lymphocyte receptors that regulate tumor development and therapy. App628304. CA-A0910/49
$24,571.80
29/01/2010
12
Parkville
3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Preventing Breast Cancer in BRCA1 and BRCA2 Mutation Carriers: kConFab Follow-Up Project. App628333. CA-A0910/51
$327,731.25
29/01/2010
36
Parkville
3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Identification of BRCAx Genes through targeted next generation sequencing. App628610. CA-A0910/52
$231,000
29/01/2010
36
Parkville
3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Ludwig Institute of Cancer Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: IL-11: A preclinical target for inflammation-associated gastrointestinal cancer. App603121. CA-A0910/45
$24,750
01/02/2010
12
Heidelberg
3084
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of New South Wales
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Too much, too soon? The impact of treatment-focused genetic testing in patients newly diagnosed with breast cancer. App630405. CA-A0910/62
$217,998
09/02/2010
42
Sydney
2052
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Characterization of the immunoregulatory capacity of antibody-based immunotherapeutics in established cancer. App628338. CA-A0910/48
$24,181.58
12/02/2010
12
Parkville
3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Curtin University of Technology
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Examination of surgical margins with a positron emission tomography (PET) probe in DCIS and invasive breast cancer. App594409. CA-A0910/64
$41,937.50
17/02/2010
24
Perth
6845
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Trans Tasman Radiation Oncology Group Limited
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Phase II Trial of Integrated Preoperative RT/Chemo with Oxaliplatin, 5-FU and FA in Locally Advanced Rectal Cancer. App626200. CA-A0910/65
$118,250
23/02/2010
40
Waratah
2298
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Newcastle
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Altered nucleotide excision repair in melanoma in response to cisplatin and UV-light irradiation. App631019. CA-A0910/63
$24,750
24/02/2010
15
Callaghan
2308
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: The role of microRNAs in the progression of ductal carcinoma in situ to invasive breast cancer. App632547. CA-A0910/69
$24,750
24/02/2010
12
Sydney
2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Timing of surgery and adjuvant chemotherapy for hepatic metastases from colorectal cancer. App632737. CA-A0910/73
$660,000
24/02/2010
53
Sydney
2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Phase 2 study of aromatase inhibitors in women with potentially hormone sensitive recurrent/metastatic gynaecological neoplasms: PARAGON. App632740. CA-A0910/75
$209,481.80
24/02/2010
39
Sydney
2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: hOGG1 in human skin carcinogenesis. App632760. CA-A0910/74
$23,443.75
24/02/2010
12
Sydney
2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Randomised trial of consumer-led familial cancer risk tool & GP triage on risk-appropriate colorectal cancer screening. App632887. CA-A0910/70
$537,901.37
24/02/2010
46
Sydney
2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Telomere trimming: a novel mechanism for preventing unlimited cellular proliferation. App633214. CA-A0910/72
$23,443.75
24/02/2010
12
Sydney
2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Queensland
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Post-operative enteral nutrition in patients with advanced epithelial ovarian cancer. App631524. CA-A0910/77
$261,910
25/02/2010
36
Brisbane
4072
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Monash University
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Pilot of a population-based prostate cancer clinical registry. App606927. CA-A0910/80
$217,387.50
26/02/2010
36
Clayton
3168
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Newcastle
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Control of malignant glioma by naturally occurring oncolytic enteroviruses. App631059. CA-A0910/68
$23,426.70
02/03/2010
12
Callaghan
2308
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
CSIRO
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: The effects of microencapsulated butyrylated high amylose maize starch and fish oil on colorectal cancer risk in rats. App593504. CA-A0910/88
$23,153.63
19/03/2010
12
Adelaide
5000
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: A randomised controlled trial evaluating a nurse-led survivorship care package (SurvivorCare) for bowel cancer survivors. App628581. CA-A0910/86
$206,250
29/03/2010
48
Parkville
3010
Cancer Australia
Support for Cancer Clinical Trials Program and Boost Cancer Research Program
Primary Care Collaborative Clinical trials Group (PC4TG) through University of Western Australia
Support for Cancer Clinical Trials Program - CA-A0910/126
$1,506,347.70
22/06/2010
36
University of WA, WA
6009
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Trans-Tasman Radiation Oncology Group Limited (TROG)
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: A randomised comparison of anastrozole commenced before and continued during adjuvant radiotherapy for breast cancer versus anastrozole and subsequent anti-oestrogen therapy delayed until after radiotherapy ApplID: 626201
$660,000
25/06/2010
48
Newcastle, NSW
2310
Cancer Australia
Support for Cancer Clinical Trials Program
Australasian Gastro-Intestinal Trials Group (AGITG) through University of Sydney
Support for Cancer Clinical Trials Program - CA-A0910/123
$1,541,030.40
25/06/2010
36
University of Sydney, NSW
2006
Cancer Australia
Support for Cancer Clinical Trials Program
Australasian Leukaemia and Lymphoma Group (ALLG)
Support for Cancer Clinical Trials Program - CA-A0910/131
$1,549,296.10
25/06/2010
36
East Melbourne,
3002
Cancer Australia
Support for Cancer Clinical Trials Program
Australasian Lung Cancer Trials Group (ALTG) through University of Sydney
Support for Cancer Clinical Trials Program - CA-A0910/121
$1,523,481.30
25/06/2010
36
University of Sydney, NSW
2006
Cancer Australia
Support for Cancer Clinical Trials Program
Australia and New Zealand Breast Cancer Trials Group (ANZBCTG)
Support for Cancer Clinical Trials Program - CA-A0910/127
$1,541,639.00
25/06/2010
36
Waratah, NSW
2298
Cancer Australia
Support for Cancer Clinical Trials Program
Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG)
Support for Cancer Clinical Trials Program - CA-A0910/129
$1,547,700.00
25/06/2010
36
Royal Melbourne Hospital, VIC
3050
Cancer Australia
Support for Cancer Clinical Trials Program
Australia New Zealand Gynaecological Oncology Group (ANZGOG) through University of Sydney
Support for Cancer Clinical Trials Program - CA-A0910/122
$1,531,997.50
25/06/2010
36
University of Sydney, NSW
2006
Cancer Australia
Support for Cancer Clinical Trials Program
Australia and New Zealand Melanoma Trials Group (ANZMTG) through University of Sydney
Support for Cancer Clinical Trials Program - CA-A0910/119
$1,534,589.43
25/06/2010
36
University of Sydney, NSW
2006
Cancer Australia
Support for Cancer Clinical Trials Program
Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) through University of Sydney
Support for Cancer Clinical Trials Program - CA-A0910/124
$1,534,308.60
25/06/2010
36
University of Sydney, NSW
2006
Cancer Australia
Support for Cancer Clinical Trials Program
Australasian Sarcoma Study Group (ASSG) through University of Melbourne
Support for Cancer Clinical Trials Program - CA-A0910/128
$1,536,150.00
25/06/2010
36
University of Melbourne, VIC
3010
Cancer Australia
Support for Cancer Clinical Trials Program
Cooperative Trials Group for Neuro-Oncology (COGNO) through University of Sydney
Support for Cancer Clinical Trials Program - CA-A0910/120
$1,242,144.20
25/06/2010
36
University of Sydney, NSW
2006
Cancer Australia
Support for Cancer Clinical Trials Program
Psycho-oncology Co-operative Research Group (PoCoG) through University of Sydney
Support for Cancer Clinical Trials Program - CA-A0910/132
$1,627,835.00
25/06/2010
36
University of Sydney, NSW
2006
Cancer Australia
Support for Cancer Clinical Trials Program
TransTasman Radiation Oncology Group (TROG)
Support for Cancer Clinical Trials Program -CA-A0910/125
$1,549,297.20
25/06/2010
36
Waratah, NSW
2287
Cancer Australia
Improved Cancer Control
Improved Cancer Control
Anti - Cancer Foundation of South Australia
Continuing Implementation of the National Cancer Data Strategy
$34,402.50
01/01/2011
3
Eastwood SA
5063
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
2010 PdCCRS: microRNA miR-211 as a novel tumour suppressor for melanoma. App1011300
$49,500.00
21/01/2011
20
Herston QLD
4006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
2010 PdCCRS: Development of a model to classify mismatch repair gene sequence variants of uncertain clinical significance. App1010859
$660,000.00
21/01/2011
48
Herston QLD
4006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Griffith University
2010 PdCCRS: ProsCan for Life: A Multimodal Supportive Care Intervention for Men with Prostate Cancer. App1008320
$329,006.70
24/01/2011
36
Nathan QLD
4111
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Cancer Council QLD
2010 PdCCRS - A multi-level investigation of inequalities in clinical and psychosocial outcomes for women after breast cancer. App1006339
$647,619.50
02/02/2011
36
Fortitude Valley, QLD
4006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
The University of Western Australia
2010 PdCCRS: Endocrine therapies for early breast cancer: health outcomes and policy implications in Australian clinical practice. Targets the National Health Priority Area of Cancer Control, specifically focussing on breast cancer treatment in Australian women. App1011488
$171,048.90
04/02/2011
49
Crawley WA
6009
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
2010 PdCCRS: Identifying markers of risk and outcome in ovarian and breast cancer via efficient of DNA methylation in peripheral blood. App1011143
$191,213.00
08/02/2011
46
Herston QLD
4006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2010 PdCCRS: Genetic and environmental factors in invasive cervical cancer: a twin study. App1008811
$429,458.70
09/02/2011
36
Parkville VIC
3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2010 PdCCRS: Fulfilling the vision of youth-friendly cancer care: How well are we meeting the psychosocial needs of AYA patients? App1010977
$164,776.70
09/02/2011
42
Parkville VIC
3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Originally University of Melbourne now Ludwig Institute of Cancer Research
2010 PdCCRS: Identifying therapeutic targets by profiling DNA repair in lung cancer CA-A1011/18. App1009892
$552,776.40
09/02/2011
46
Heidelberg VIC
3084
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2010 PdCCRS: Personalised breast cancer risk prediction in BRCA mutation carriers. App1007765
$152,780.10
09/02/2011
63
Parkville VIC
3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2010 PdCCRS: Identification of Men with a genetic predisposition to Prostate Cancer: targeted screening in BRCA1/2 mutation carriers and controls - The Impact study. App1006349
$465,329.70
09/02/2011
40
Parkville VIC
3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2010: A phase III randomised trial of postmastectomy chest wall irradiation in intermediate risk operable breast cancer. App1004707. CA-A1011/15
$561,000
09/02/2011
36
Parkville
3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
The Australian National University
2010 PdCCRS: Targeting of two Aspects of Metabolism (TOTAM) for cancer therapy. App1008861
$546,165.40
14/02/2011
36
Canberra ACT
200
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of New South Wales
2010 PdCCRS: Identification of anti-apoptotic signalling pathways in malignant gliomas. App1010484
$49,500.00
15/02/2011
12
Sydney NSW
2052
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of New South Wales
2010 PdCCRS: Role of dietary compounds on PGC-1 alpha methylation in colorectal cancer. App1010361
-
15/02/2011
36
Sydney NSW
2052
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of New South Wales
2010 PdCCRS: Targeting drug resistant genes in brain cancer: delivery of siRNA to improve cancer therapy. App1003650
$49,500.00
15/02/2011
19
Sydney NSW
2052
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Queensland
Autofluorescence imaging for early detection and surgical margin delineation of oral cancers and pre-cancers. App1009996
$558,131.20
21/02/2011
44
St Lucia, QLD
4072
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Adelaide
The role of CD123 in MDSA and AML. App1010336
$316,276.40
24/02/2011
36
North Terrace, SA
5005
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2010 PdCCRS: Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma - a randomised phase III trial. App1009485
$650,111.00
01/03/2011
60
Sydney, NSW
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2010 PdCCRS: A randomised, placebo-controlled trial of concurrent cediranib [AZD2171] with platinum - based chemotherapy & maintenance cediranib in women with platinum sensitive relapsed ovarian cancer: ICON 6. App1006602
$270,597.80
01/03/2011
24
Sydney, NSW
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2010 PdCCRS: Tumour protein D52 over-expression and DNA repair in cancer. App1007020
$48,132.40
01/03/2011
12
Sydney, NSW
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2010 PdCCRS: START Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed with Favourable Risk Prostate Cancer. App1004932
$329,320.20
01/03/2011
38
Sydney, NSW
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Curtin University of Technology
2010 PdCCRS: Meeting the education and support needs of women with breast cancer who are referred for radiotherapy: A multiple - baseline study. App1006458
$220,993.30
01/03/2011
59
Perth, WA
6845
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Adelaide
2010 PdCCRS: A novel approach to predict metastatic potential of prostate cancer at diagnosis. App1012337
$650,905.20
01/03/2011
36
Adelaide, SA
5005
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2010 PdCCRS: The impact of aberrant progesterone signalling on lineage specification during early malignant transformation. App1009094
$48,129.40
01/03/2011
12
Sydney, NSW
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2010 PdCCRS: Alternative lengthening of Telomeres (ALT) in lung cancer: analysis of effects on patient outcomes and development of a blood test. App1012032
$48,981.90
01/03/2011
12
Sydney, NSW
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2010 PdCCRS: NITRO - A randomised, phase 3 trial of adding nitro-glycerine to first line chemotherapy for advanced non - small cell lung cancer. App1006315
$656,421.70
01/03/2011
36
Sydney, NSW
2006
Cancer Australia
Improved Cancer Control
Improved Cancer Control
Cancer Institute NSW
Maintaining the eviQ Primary Health Care modules
$119,900.00
01/03/2011
16
Australian Technology Park, NSW
2015
Cancer Australia
Improved Cancer Control
Improved Cancer Control
The Australian Lung Foundation
Travel grants for lung cancer nurses to attend the International Lung Cancer Conference in Amsterdam
$22,800.00
29/03/2011
6
Bowen Hills, QLD
4006
Cancer Australia
Improved Cancer Control
Improved Cancer Control
Queensland Health
Cancer care coordination for Indigenous people residing in Far North Queensland
$438,743.80
25/05/2011
18
Brisbane, QLD
4000
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Monash University
2010 PdCCRS: Determining the causes of observed variation in survival after diagnosis of prostate cancer. App1010384
$627,607.20
30/05/2011
36
Clayton, VIC
3800
Cancer Australia
Improved Cancer Control
Improved Cancer Control
Clinical Oncology Society of Australia
Building Cancer Support Networks Initiative - Better Cancer Support through Consumers (BCSN)
$2,970,000.00
02/06/2011
12
Sydney. NSW
2010
Cancer Australia
Data
Improved Cancer Control
Women's and Children's Hospital
For the provision of Pilot Testing of a Data Set Specifications (DSS) for Adolescents and Young Adults with Cancer
$16,648.50
24/06/2011
5
North Adelaide, SA
5006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
Sequencing the ovarian cancer genome: molecular determinants of tumour growth & treatment failure. App1004673
$660,000.00
30/06/2011
36
Parkville, VIC
3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland University of Technology
Skin cancer prevention & early detection for Generation Y. App1011999
$343,776.40
30/06/2011
36
Brisbane, QLD
4001
Cancer Australia
Data
Improved Cancer Control
Austin Health
Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period.
$35,255.54
30/06/2011
6
Heidelberg VIC
3084
Cancer Australia
Data
Improved Cancer Control
Prince Charles Hospital
Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period.
$18,820.20
30/06/2011
6
Chermside, QLD
4032
Cancer Australia
Data
Improved Cancer Control
Royal Hobart Hospital (Department of Health and Human Services)
Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period.
$12,425.24
30/06/2011
6
Hobart, TAS
7000
Cancer Australia
Data
Improved Cancer Control
Nepean Hospital
Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period.
$27,056.13
30/06/2011
6
Penrith, NSW
2751
Cancer Australia
Data
Improved Cancer Control
Peter MacCallum Cancer Centre
For the provision of Pilot Testing of a Data Set Specifications (DSS) for Adolescents and Young Adults with Cancer
$36,960.00
30/06/2011
5
A'Beckett Street, VIC
8006
Cancer Australia
Data
Improved Cancer Control
South Eastern Sydney Local Health District
Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period.
$16,376.80
27/07/2011
4
Randwick, NSW
2031
Cancer Australia
Improved Cancer Control
Improved Cancer Control
Breast Cancer Network Australia
For the provision of projects that aim to strengthen support for women with breast cancer
$1,366,200.00
04/11/2011
31
Camberwell, VIC
3124
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2011 PdCCRS – The role of adjuvant chemotherapy in high-risk endometrial cancer. App1027151
$330,965.80
09/01/2012
47
Sydney, NSW
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2011 PdCCRS – Phase III trial of Concurrent and Adjuvant Temozolomide chemotherapy in non-1p/19q non deleted anaplastic glioma - The CATNON Intergroup Trial. App1026842
$217,896.25
09/01/2012
36
Sydney, NSW
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2011 PdCCRS - Evaluation of a web-based tool for estimating and explaining prognosis in advanced cancer. App1032121
$139,933.75
09/01/2012
48
Sydney, NSW
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2011 PdCCRS - Evaluation of a psychological and educational intervention for fear of cancer recurrence; A cluster randomised controlled trial. App1022584
$182,124.07
09/01/2012
64
Sydney, NSW
2006
Cancer Australia
Improved Cancer Control
Improved Cancer Control
Breast Cancer Network Australia
Hope and Hurdles Pack
$165,000.00
01/02/2012
5
Camberwell, VIC
3124
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Ludwig Institute for Cancer Research
2011 PdCCRS - Discovery of colorectal cancer subtype associated tumour suppressor genes using next-generation sequencing and high throughput functional genomics. App1030098
$482,476.50
02/02/2012
36
Heidelberg, VIC
3084
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Edith Cowan University
2011 PdCCRS - Can exercise ameliorate treatment toxicity during the initial phase of testosterone suppression in prostate patients? Is this more effective than delayed rehabilitation and what is the time course and persistence of benefits? App1029901
$163,634.45
02/02/2012
46
Joondalup, WA
6027
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of New South Wales
2011 - PdCCRS 'ReCaPTure LiFe': A phase 11 randomised trial of a psychological intervention to support adolescent and young adult cancer survivors. App1022868
$148,811.45
17/02/2012
36
Sydney, NSW
2052
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Garvan Institute of Medical Research
2011 - PdCCRS - The role of p53-regulated microRNAs in epithelial to mesenchymal transition, and their potential as therapeutic targets against metastatic breast cancer. App1034561
$24,750.00
17/02/2012
12
Sydney. NSW
2010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Menzies Research Institute
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Integrative genomic approaches to understanding the genetics of prostate cancer. App ID: 544938; Ref: CA-A0809/11
$567,270
17/02/2012
68
Hobart, TAS
7000
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Wollongong
2011 - PdCCRS -Quantifying the impact of imaging choice for breast cancer radiotherapy. App1033237
$143,585.20
21/02/2012
41
Wollongong, NSW
2522
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
The State of Queensland through Queensland Health via The Princess Alexandra Hospital Metro South District
2011 - PdCCRS - A randomised Phase III trial of High Dose Palliative Radiotherapy (HDPRT) versus concurrent Chemotherapy and HDPRT (C-HDPRT) in patients with Good performance Status. Locally Advanced/Small Volume Metastatic Non-small Cell Lung Cancer not suitable for Radical Chemo-therapy. App1030265
$327,214.80
21/02/2012
72
Woolloongabba, QLD
4102
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Western Australia
2011 - PdCCRS - The initiation of the cellular immune response to cutaneous melanoma. App1034730
$24,750.00
21/02/2012
12
Heidelberg, VIC
3084
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2011 - PdCCRS - Inhibition of Glioblastoma Invasion by Novel Dynamin Ring Stabilisers. App1021331
$24,399.38
21/02/2012
12
Sydney, NSW
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2011 - PdCCRS - Mechanism of 133p53 isoform oncogenicity. App1030408
$24,399.38
21/02/2012
12
Sydney, NSW
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2011 - PdCCRS - Ginkgo biloba preserves cognitive function in women treated with adjuvant chemotherapy for early breast cancer: a double-blind, placebo-controlled, randomised phase III trial. App1029819
$220,000.00
21/02/2012
71
Sydney, NSW
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2011 - PdCCRS - The role of Single Stranded DNA Binding Proteins in the Alternative Lengthening of Telomeres mechanism. App1030040
$48,798.75
21/02/2012
24
Sydney, NSW
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2011 - PdCCRS - The use of RNAi to identify new therapeutic targets for malignant mesothelioma. App1031821
$411,650.80
21/02/2012
36
Sydney, NSW
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2011 PdCCRS - Targeting dormancy in metastatic breast cancer. App1020272
$148,179.90
23/02/2012
36
Melbourne, VIC
3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2011 PdCCRS - Defining the hereditary contribution to ovarian cancer: The role of mismatch repair genes. App1024096
$614,090.40
23/02/2012
41
Melbourne, VIC
3010
Cancer Australia
Improved Cancer Control
Improved Cancer Control
Breast Cancer Network Australia
My Journey Kit
$248,600.00
23/02/2012
6
Camberwell, VIC
3124
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of New South Wales
2011 - PdCCRS - Thromboembolism in Cancer. App1026790
$24,750.00
20/03/2012
20
Sydney, NSW
2052
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2011 - PdCCRS - Determining Predictors of Sensitivity to Chk Inhibitors in Metastatic Melanoma. App1029585
$651,585.00
20/03/2012
46
Melbourne , VIC
3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
2011 - PdCCRS - Salinomycin a potential glioma stem cell targeting therapy. App1031303
$240,862.50
20/03/2012
12
Brisbane, QLD
4006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Adelaide
2011 - PdCCRS - Androgen receptor action in the prostate cancer microenvironment. App1032970
$316,571.20
20/03/2012
43
Adelaide, SA
5005
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Adelaide
2011 - PdCCRS - Reactivating the p53 pathway as a novel therapeutic approach to cancer treatment. App1034715
$49,500.00
20/03/2012
24
Adelaide, SA
5005
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Adelaide
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2011 - A novel method to detect and characterise dysplasia and early cancer in Barrett's oesophagus. Appl ID: 1031971
$24,750
20/03/2012
24
Adelaide, SA
5005
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Adelaide
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2011: Is elevated N-cadherin expression a poor prognostic indicator in multiple myeloma patients. Appl ID: 1030518
$290,766.30
20/03/2012
48
Adelaide, SA
5005
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Newcastle
2011 - PdCCRS - The therapeutic potential of targeting S100A2 calcium-binding protein in pancreatic cancer. App1033781
$44,362.50
03/04/2012
27
Callaghan, NSW
2308
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
Cancer Council South Australia
Supporting people with Cancer grant initiative
$85,800.00
12/06/2012
24
Eastwood, SA
5063
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
The Prince Charles Hospital
Supporting people with Cancer grant initiative
$88,000.00
12/06/2012
30
Brisbane, QLD
4032
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
Paediatric Integrated Cancer Service
Supporting people with Cancer grant initiative. CA-A1112/42
$86,361.00
12/06/2012
25
Parkville, VIC
3056
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
Australian Lung Foundation
Supporting people with Cancer grant initiative
$83,050.00
12/06/2012
24
Bowen Hills, QLD
4006
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
BreaCan
Supporting people with Cancer grant initiative
$88,000.00
12/06/2012
24
Melbourne, VIC
3000
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
Cancer Council VIC
Supporting people with Cancer grant initiative
$86,460.00
12/06/2012
24
Carlton, VIC
3053
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
CanRevive
Supporting people with Cancer grant initiative
$87,934.00
25/06/2012
24
Sydney, NSW
2000
Cancer Australia
Improved Cancer Control
Improved Cancer Control
The Medical Oncology Group of Australia
To support the attendance at the ACORD Workshop of four (4) early career oncology clinical researchers from Australia selected as participants and the attendance as a faculty member of the Cancer Australia Chair in Quality of Life Research.
$24,750.00
26/06/2012
1
Sydney, NSW
2000
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
Cancer Voices Victoria
Supporting people with Cancer grant initiative
$84,392.00
27/06/2012
24
Carlton, VIC
3053
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
Australian Cancer Survivorship
Supporting people with Cancer grant initiative
$88,000.00
28/06/2012
25
East Melbourne, VIC
3002
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
Cancer Council NSW
Supporting people with Cancer grant initiative
$88,000.00
28/06/2012
25
Woolloomooloo, NSW
2011
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
University of South Australia
Supporting people with Cancer grant initiative
$82,500.00
28/06/2012
24
Adelaide, SA
5000
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
Menzies School of Health and Research
Supporting people with Cancer grant initiative
$87,774.00
29/06/2012
24
Spring Hill, QLD
4000
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
Cancer Council TAS
Supporting people with Cancer grant initiative
$16,702.40
29/06/2012
24
Hobart, TAS
7000
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Wellington Aboriginal Corporation
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$2,260
03/10/2012
3
Wellington, NSW
2820
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Top End Remote Health Branch
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$2,500
03/10/2012
3
Winnellie, NT
822
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
South Coast Medical Service Aboriginal Corporation
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$2,490
03/10/2012
3
Nowra, NSW
2541
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Napranum Primary Health Care Clinic
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$1,850
03/10/2012
3
Wiepa, QLD
4874
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Kalwun Development Corporation Limited
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$2,500
03/10/2012
3
Miami, QLD
4220
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Inala Community Health Centre
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$1,600
03/10/2012
3
Inala, QLD
4077
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Illawarra Womens Health Centre
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$2,500
03/10/2012
3
Warilla, NSW
2528
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Goulburn Valley Health
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$2,600
03/10/2012
3
Wodonga, VIC
3689
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Western NSW Local Health District, Dubbo Community Health Centre
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$4,000
03/10/2012
3
Dubbo, NSW
2830
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Dareton Primary Health Centre
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$1,500
03/10/2012
3
Dareton, NSW
2717
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Bulgarr Ngaru Medical Aboriginal Corporation
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$4,000
03/10/2012
3
Grafton, NSW
1256
Cancer Australia
Aboriginal and Torres Strait Islander Registered Training Organisation Grants
Indigenous Wellbeing Centre Ltd
To conduct unit of competency and provide information and support to women with breast cancer for Aboriginal and/or Torres Strait Islander Health Workers.
$11,000
26/10/2012
7.5
Bundaberg QLD
4670
Cancer Australia
Aboriginal and Torres Strait Islander Registered Training Organisation Grants
QLD Aboriginal and Torres Strait Islander Health Worker Education Program Aboriginal Corporation
To conduct unit of competency and provide information and support to women with breast cancer for Aboriginal and/or Torres Strait Islander Health Workers.
$11,000
26/10/2012
7.5
Cairns, QLD
4870
Cancer Australia
Aboriginal and Torres Strait Islander Registered Training Organisation Grants
Central Australian Remote Health Development Services Ltd
To conduct unit of competency and provide information and support to women with breast cancer for Aboriginal and/or Torres Strait Islander Health Workers
$11,000
28/11/2012
7
Alice Springs
870
Cancer Australia
Aboriginal and Torres Strait Islander Registered Training Organisation Grants
Kimberley Aboriginal Medical Services Council Inc
To conduct unit of competency and provide information and support to women with breast cancer for Aboriginal and/or Torres Strait Islander Health Workers.
$11,000
28/11/2012
6
Broome
6725
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Cancer Council Queensland
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Improving the Psychosocial Health of People with Cancer and their Carers: A Community-Based Approach. App561701. CA-A0809/07
$297,156.20
13/01/2013
47
Fortitude Valley
4006
Cancer Australia
Ralph Lauren Pink Pony 12-13
Ralph Lauren Pink Pony Campaign Scholarships
$17,500
14/02/2013
10
Various
Various
Cancer Australia
Improved Cancer Control
Southern Adelaide Local Area Health Network: Repatriation General Hospital
Prostate Cancer Data Set Specification Pilot Project
$19,121.81
25/02/2013
5
Daws Park
5041
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Murrumbidgee Medicare Local
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$2,800
28/02/2013
5
Tumut, NSW
2720
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: High Risk genes for Lobular Breast Cancer. Appl ID 1047347.
$100,000
01/03/2013
36
Parkville
3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Technology Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Molecular characterisation of a novel target in multiple myeloma. Appl ID 1050067.
$23,745.25
01/03/2013
15
Broadway
2007
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
The Australian National University
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Equivalence of sun exposure and vitamin D supplementation in vitamin D insufficiency. Appl ID 1045198
$582,911
01/03/2013
58
Acton
200
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Walter and Eliza Hall Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Innate immune cell protection and colon cancer. Appl ID 1050241
$26,826.53
01/03/2013
12
Parkville
3052
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: PETACC-6: Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer. Appl ID 1048035
$123,331
04/03/2013
49
The University of Sydney
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Production of Off The Shelf T-cells Expressing a Non-MHC Restricted CD19 Specific Chimeric Antigen Receptor for use in a Phase I Study of T-cell Therapy of Relapsed and Refractory Bcell Malignancies (UNI-T Study). Appl ID 1047454
$47,500
04/03/2013
37
University of Sydney
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Investigating the mechanism of action of the cancer-associated enzyme telomerase using disease linked telomerase mutants. Appl ID 1048376
$24,972.75
04/03/2013
12
University of Sydney
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: The cost-effectiveness of adjuvant whole brain radiotherapy for melanoma brain metastases: a trial-based and modelled economic evaluation. Appl ID 1046923
$184,475
04/03/2013
36
University of Sydney
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: ICON8: An international multi-stage randomised phase III trial of dose-fractionated chemotherapy compared to standard three-weekly chemotherapy for women with newly diagnosed epithelial ovarian cancer. Appl ID 1044344
$257,241
04/03/2013
36
University of Sydney
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: The Use and Impact of High Cost Targeted Cancer Medicines: Theory and Reality. Appl ID 1050648
$133,002
04/03/2013
46
University of Sydney
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of New South Wales
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Testing of biomarkers of human papillomavirus on anal cytology in homosexual men to predict the presence of high-grade anal intraepithelial neoplasia and its progression and persistence. Appl ID 1043299
$48,137.50
11/03/2013
32
Kensington
2232
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2009 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Translation of clinical and functional imaging data to brachytherapy treatment optimisation for prostate cancer ApplID: 628592
$86,395.83
27/03/2013
48
Parkville VIC
3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
2008 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Improving Outcomes for Women with Endometrial Cancer: Follow-up, survival and quality of life ApplID: 552468
$656,466.80
27/03/2013
60
Herston QLD
4006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Monash University
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Defining Epigenetic Changes in Prostate Cancer Stroma. Appl ID 1044458
$597,987
31/03/2013
36
Clayton
3800
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Garvan Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Characterising a new mode of regulation of the beta-catenin pathway in colorectal cancer. Appl ID 1049846.
$49,945.50
01/04/2013
24
Darlinghurst
2010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Adelaide
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Mechanism and targeting of castration-resistant prostate cancer. Appl ID 1043482.
$270,569
01/04/2013
36
Adelaide
5005
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Adelaide
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Targeting the androgen receptor in triple negative breast cancer. Appl ID 1043497.
$196,474.70
01/04/2013
36
Adelaide
5005
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Investigating the tumour-promoting phenotype of cancer-associated fibroblasts in serous epithelial ovarian cancer. Appl ID 1050101
$24,640.25
01/04/2013
20
University of Sydney
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland University of Technology
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Mirena ± Weight Loss to treat early Endometrial Cancer: (MAxWEL Trial). Appl ID 1044900
$600,000
01/04/2013
36
Kelvin Grove
4059
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Preferences for adjuvant chemotherapy in early non-small-cell lung cancer: what makes it worthwhile?: ApplID: 570905
$316,167.50
09/04/2013
59
University of Sydney
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Genomic determinants of chemosensitivity in ovarian cancer ApplID: 632595
$604,725
09/04/2013
39
University of Sydney
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Novel MicroRNA regulators in the Breast Cancer EMT ApplID: 628720
$281,620.90
18/04/2013
46
Parkville VIC
3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Adelaide
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: A pharmacodynamic study of the heat shock protein 90 (Hsp90) inhibitor, AUY922, in high-risk, localised prostate cancer. Appl ID 1050880.
$360,977
01/05/2013
59
Adelaide
5005
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Randomised phase III study of preop-chemoradiotherapy versus preop-chemotherapy for resectable gastric cancer: Appl ID: 570996
$595,301.66
07/05/2013
72
University of Sydney
2006
Cancer Australia
Improved Cancer Control
Anti-Cancer Council of Victoria
Capturing information on clinical stage, metastases at diagnosis and cancer recurrence employing IT solutions
$1,647,499
07/05/2013
42
Carlton, VIC
3053
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: The use and impact of cancer medicines in real world clinical practice: Evaluation in a cohort of elderly Australians. Appl ID: 568773
$459,525
23/05/2013
59
University of Sydney
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Peter MacCallum Cancer Centre
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Randomised phase III trial to assess response adapted therapy using PET in newly diagnosed advanced Hodgkin Lymphoma. Appl ID: 628842
$124,666.67
23/05/2013
42
Peter MacCallum Cancer Centre
3002
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: RNA Loading of Tumour Associated Antigens and the Activation of Blood Dendritic Cells for Prostate Cancer Immunotherapy: Appl ID: 543713
$327,195
23/05/2013
74
University of Sydney
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Solving Unknown Primary cancER – SUPER. Appl ID 1048193.
$599,381
01/06/2013
61
Parkville
3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Accelerating First-Line Chemotherapy to Improve Cure Rates for Advanced Germ Cell Tumours: An Australian-Led, International Randomised Trial. Appl ID 1041733
$252,583.48
01/06/2013
50
University of Sydney
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Adding mitomycin C to intravesical BCG for high-risk, non-muscle-invasive bladder cancer: a randomised phase 3 trial. Appl ID 1041651
$457,143.17
01/06/2013
58
University of Sydney
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Germline Copy Number Variants are Genetic Risk Factors for Familial Colorectal Cancer. Appl ID 1052035
$24,420.50
01/06/2013
19
Herston
4028
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: RAD51 overexpression regulates pro-metastatic gene expression profiles of aggressive metastatic triple negative breast cancer. Appl ID 1050903
$24,764
01/06/2013
12
Herston
4028
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: A Phase II study to evaluate the safety and potential benefit of intraperitoneal (IP) bevacizumab to control symptomatic malignant ascites in patients with chemotherapy resistant ovarian cancers: REZOLVE (ANZGOG-1101). Appl ID 1050134
$277,958
28/06/2013
36
The University of Sydney, NSW
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: Identification of novel permissive mutations representing acquired vulnerabilities in lung cancer - CA-A1314/20 ApplID: 1070515
$50,000
04/02/2014
47
Herston, QLD
4028
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Walter and Eliza Hall Institute of Medical Research
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Regulating BAK and BAX conversion to death-inducing oligomers. App1069567 - CA-A1314/18
$27,500
15/02/2014
12
Parkville, VIC
3052
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Garvan Institute of Medical Research
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): From functional genomics to precision medicine: The therapeutic potential of targeting Rho/ROCK signalling in pancreatic cancer. App1065022 - CA-A1314/04
$599,997
17/02/2014
36
Darlinghurst, NSW
2010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Princess Alexandra Hospital
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): A Randomised Trial of Postoperative Radiation Therapy Following Wide Excision of Neurotropic Melanoma of the Head and Neck. App1060687 Ref: CA1314-12
$335,000
20/02/2014
48
Woolloongabba, Qld
4102
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Understanding DNA integrity and telomerase in acute myeloid leukaemia stem cell function. App 1059292: CA-A1314/17
$25,000
27/02/2014
12
Herston, QLD
4028
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Ludwig Institute for Cancer Research
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Targeting the dimerisation arm of EGFR- biological effects and therapeutic implications. App 1063413: CA-A1314/23
$28,167.98
27/02/2014
24
Heidelberg, VIC
3084
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of NSW
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: A multicentre phase II randomised controlled trial of a parent/carer-targeted intervention to improve quality of life in families of young cancer survivors. ID 1065428. CA-A1314/02
$457,353
27/02/2014
48
Kensington
2052
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Maximising benefits and minimising harms in the BreastScreen program: a population health economics modelling approach. App 1066771: CA-A1314/06
$593,893
05/03/2014
48
Parkville, VIC
3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland University of Technology
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Mimicking the HSC niche and enabling HSC self-renewal in vitro. App1060928: CA-A1314/21
$50,000
05/03/2014
24
Kelvin Grove, QLD
4059
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland University of Technology
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): miRSNPs as novel diagnostic and prognostic biomarkers for prostate cancer. App 1068321: CA-A1314/22
$50,000
05/03/2014
24
Kelvin Grove, QLD
4059
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: ECHO trial: Exercise during CHemotherapy for Ovarian cancer. ID 1063509
$300,000
18/03/2014
36
Sydney
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in men at higher genetic risk and controls – The IMPACT study. App 1059423: CA-A1314/01
$292,151
21/03/2014
44
Parkville, VIC
3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: Quantifying genetic risk in sarcoma and translation into health outcomes. ID1067094. CA-A1314/09
$597,793
21/03/2014
36
University of Melbourne
3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: Novel Therapies to Treat Brain Metastatic Breast Cancer. ID 1067045. CA-A1314/10
$398,447
28/03/2014
36
University of Melbourne
3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: ASCOLT: Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers. An International, Multi-centre, Double Blind, Randomised Trial. ID1068044. CA-A1314/08
$276,811.50
28/03/2014
36
Sydney
2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Monash University
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Nuclear receptors and their functions in breast cancer stroma: identification of novel therapeutic targets. App 1058516: CA-A1314/19
$49,518.50
01/04/2014
24
Clayton, VIC
3800
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Investigation of molecular imaging and serum biomarkers to identify lung injury and enable individualised radiation therapy for lung cancers. App1060919
$498,012
01/04/2014
49
Parkville, VIC
3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Monash University
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): An inhalable dendrimer-based delivery platform for the targeted treatment of primary and secondary lung cancers. App 1070184: CA-A1314/11
$452,383
23/04/2014
36
Clayton, VIC
3800
Cancer Australia
Supporting People with Cancer Grant initiative
Paediatric Integrated Cancer Service
Supporting people with Cancer grant initiative
$86,361.00
16/05/2014
25
Parkville VIC
3052
Cancer Australia
Supporting People with Cancer Grant initiative
The Prince Charles Hospital
Supporting people with Cancer grant initiative
$88,000.00
16/05/2014
30
Brisbane, QLD
4032
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Phase 2 study of aromatase inhibitors in women with potentially hormone sensitive recurrent/metastatic gynaecological neoplasms: PARAGON. App 1063014: CA-A1314/69
$546,676
20/05/2014
36
The University of Sydney, NSW
2006
Cancer Australia
Jeannie Ferris Cancer Australia Recognition Award 2014
Various
To recognise outstanding contribution in gynaecological cancer through the Jeannie Ferris Cancer Australia Recognition Award
$4,000
26/05/2014
NA
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): A randomised trial of stereotactic radiotherapy versus conventional radiotherapy for stage I non-small cell lung cancer. App1060822 Ref: CA-1314/14
$320,000
01/06/2014
43
Parkville, VIC
3010
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Arts out West Inc
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/04
$2,200
05/06/2014
3
Bathurst, NSW
2795
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Cancer Council NT Inc
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/06
$4,400
05/06/2014
3
Casuarina, NT
810
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Central and North West Queensland Medicare Local
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/07
$3,993
05/06/2014
3
Normanton QLD
4890
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Country Health SA Local Health Network Inc
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/08
$3,000
05/06/2014
3
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Hume Regional Integrated Cancer Service
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/09
$3,410
05/06/2014
3
Shepparton, VIC
3630
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Institute for Urban Indigenous Health
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/11
Recommended